News | Agbiopro

top of page

Search

Targeted protein degradation: a promise for undruggable proteins

Targeted protein degradation: a promise for undruggable proteins

Targeted protein degradation: a promise for undruggable proteins

agbiopro

May 19, 20210 min read

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

agbiopro

Aug 19, 20200 min read

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

agbiopro

Aug 19, 20200 min read

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

agbiopro

Aug 3, 20200 min read

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

agbiopro

Aug 3, 20200 min read

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

agbiopro

Jun 30, 20200 min read

Agrifood corporates turn to startups to hedge disruptions and get an edge on trends

Agrifood corporates turn to startups to hedge disruptions and get an edge on trends

Agrifood corporates turn to startups to hedge disruptions and get an edge on trends

agbiopro

May 5, 20200 min read

Cambridge biotech launches with $50M to target 'junk DNA'

Cambridge biotech launches with $50M to target 'junk DNA'

Cambridge biotech launches with $50M to target 'junk DNA'

agbiopro

Apr 29, 20200 min read

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

agbiopro

Mar 20, 20200 min read

After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work

After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work

After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work

Sanofi- and Gilead Sciences-backed Nurix Therapeutics is following suit with rival biotech Kymera in raising a major cash haul for its...

agbiopro

Mar 15, 20201 min read

Vertex, CRISPR’s gene-editing treatment for blood disorders shows promise in early data

Vertex, CRISPR’s gene-editing treatment for blood disorders shows promise in early data

Vertex, CRISPR’s gene-editing treatment for blood disorders shows promise in early data

agbiopro

Nov 21, 20190 min read

SAVE the date 1st ISR-Openscreen workshop and conference

SAVE the date 1st ISR-Openscreen workshop and conference

SAVE the date 1st ISR-Openscreen workshop and conference

Dear colleagues and fellow "drug discoverers", we are happy to invite you to the first ISR-Openscreen workshop and conference, which will...

agbiopro

Nov 3, 20191 min read

Metabolic landscape of the tumor microenvironment at single cell resolution

Metabolic landscape of the tumor microenvironment at single cell resolution

Metabolic landscape of the tumor microenvironment at single cell resolution

agbiopro

Aug 24, 20190 min read

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating S

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating S

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating S

agbiopro

Aug 21, 20190 min read

NHS To Create National Artificial Intelligence Lab Following £250 Million Investment Boost

NHS To Create National Artificial Intelligence Lab Following £250 Million Investment Boost

NHS To Create National Artificial Intelligence Lab Following £250 Million Investment Boost

agbiopro

Aug 8, 20190 min read

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

agbiopro

Aug 8, 20190 min read

Bayer sees potential future business in plant-based meat market

Bayer sees potential future business in plant-based meat market

Bayer sees potential future business in plant-based meat market

agbiopro

Aug 8, 20190 min read

FDA approves Medtronic's 'artificial pancreas,' the world's first

FDA approves Medtronic's 'artificial pancreas,' the world's first

FDA approves Medtronic's 'artificial pancreas,' the world's first

On Wednesday, the FDA approved Medtronic’s hybrid closed-loop system, the world’s first “artificial pancreas.” The agency nod comes...

agbiopro

Aug 7, 20191 min read

A good glimpse on cell therapy efforts ongoing in oncology

A good glimpse on cell therapy efforts ongoing in oncology

A good glimpse on cell therapy efforts ongoing in oncology

agbiopro

Jul 28, 20190 min read

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Synthetic biology is driving a new era of medicine through the genetic programming of living cells. One particular area of focus has been...

agbiopro

Jul 13, 20191 min read

bottom of page